Webinar: Rare diseases: Natural history studies for drug development
1:00:36
Description
Related Videos
View More
View Less
1:00:36
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
57:01
1:14:41
58:34
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
1:02:03
32:11